SANDOZ ESTRADIOL DERM 75 PATCH

Maa: Kanada

Kieli: englanti

Lähde: Health Canada

Aktiivinen ainesosa:

ESTRADIOL (ESTRADIOL HEMIHYDRATE)

Saatavilla:

SANDOZ CANADA INCORPORATED

ATC-koodi:

G03CA03

INN (Kansainvälinen yleisnimi):

ESTRADIOL

Annos:

75MCG

Lääkemuoto:

PATCH

Koostumus:

ESTRADIOL (ESTRADIOL HEMIHYDRATE) 75MCG

Antoreitti:

TRANSDERMAL

Kpl paketissa:

8

Prescription tyyppi:

Prescription

Terapeuttinen alue:

ESTROGENS

Tuoteyhteenveto:

Active ingredient group (AIG) number: 0106457036; AHFS:

Valtuutuksen tilan:

APPROVED

Valtuutus päivämäärä:

2006-01-11

Valmisteyhteenveto

PRODUCT MONOGRAPH
SANDOZ ESTRADIOL DERM 50, 75 AND 100 ESTRADIOL HEMIHYDRATE (ESTRADIOL-17Β)
TRANSDERMAL THERAPEUTIC SYSTEM
4, 6 AND 8 MG ESTRADIOL PATCHES
CORRESPONDING TO
50 MCG/DAY, 75 MCG/DAY AND 100 MCG/DAY DELIVERY
ESTROGEN
Sandoz Canada Inc.
145 Jules-Léger
Date of Revision: March 19, 2009
Boucherville, QC, Canada
J4B 7K8
CONTROL NUMBER: 120474
_ _
_Sandoz Estradiol Derm _
_Page 2 of 34 _
_ _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL
INFORMATION.........................................................................................
3
SUMMARY
PRODUCT
INFORMATION...............................................................................................................
3
INDICATIONS
AND
CLINICAL
USE
....................................................................................................................
3
CONTRAINDICATIONS
.........................................................................................................................................
3
WARNINGS
AND
PRECAUTIONS
........................................................................................................................
4
ADVERSE
REACTIONS........................................................................................................................................
11
DRUG
INTERACTIONS
........................................................................................................................................
12
DOSAGE
AND
ADMINISTRATION
....................................................................................................................
14
OVERDOSAGE
......................................................................................................................................................
16
ACTIONS
AND
CLINICAL
PHARMACOLOGY.................................................................................................
16
STORAGE
AND
STABILITY
.....................................................................................................................